280 related articles for article (PubMed ID: 23472852)
21. Individually monitoring ligand-induced changes in the structure of the GABAA receptor at benzodiazepine binding site and non-binding-site interfaces.
Sharkey LM; Czajkowski C
Mol Pharmacol; 2008 Jul; 74(1):203-12. PubMed ID: 18424553
[TBL] [Abstract][Full Text] [Related]
22. Effects of bilobalide, ginkgolide B and picrotoxinin on GABA
Ng CC; Duke RK; Hinton T; Johnston GAR
Eur J Pharmacol; 2017 Jul; 806():83-90. PubMed ID: 28416372
[TBL] [Abstract][Full Text] [Related]
23. Hops compounds modulatory effects and 6-prenylnaringenin dual mode of action on GABA
Benkherouf AY; Logrén N; Somborac T; Kortesniemi M; Soini SL; Yang B; Salo-Ahen OMH; Laaksonen O; Uusi-Oukari M
Eur J Pharmacol; 2020 Apr; 873():172962. PubMed ID: 32001220
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of the antiepileptic drug candidate, padsevonil, on GABA
Niespodziany I; Ghisdal P; Mullier B; Wood M; Provins L; Kaminski RM; Wolff C
Epilepsia; 2020 May; 61(5):914-923. PubMed ID: 32297665
[TBL] [Abstract][Full Text] [Related]
25. The role of loops B and C in determining the potentiation of GABA
Moody OA; Jenkins A
Pharmacol Res Perspect; 2018 Dec; 6(6):e00433. PubMed ID: 30459951
[TBL] [Abstract][Full Text] [Related]
26. Variations on a scaffold - Novel GABA
Iorio MT; Rehman S; Bampali K; Stoeger B; Schnürch M; Ernst M; Mihovilovic MD
Eur J Med Chem; 2019 Oct; 180():340-349. PubMed ID: 31325782
[TBL] [Abstract][Full Text] [Related]
27. EDPC: a novel high affinity ligand for the benzodiazepine site on rat GABA(A) receptors.
Thomet U; Furtmüller R; Sieghart W; Le Hyaric-Almeida M; Rousseau JF; Dodd RH; Venault P; Chapouthier G; Sigel E
Neurosci Lett; 1999 Jul; 269(2):63-6. PubMed ID: 10430505
[TBL] [Abstract][Full Text] [Related]
28. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
29. Bicuculline and gabazine are allosteric inhibitors of channel opening of the GABAA receptor.
Ueno S; Bracamontes J; Zorumski C; Weiss DS; Steinbach JH
J Neurosci; 1997 Jan; 17(2):625-34. PubMed ID: 8987785
[TBL] [Abstract][Full Text] [Related]
30. Alcohol selectivity of β3-containing GABAA receptors: evidence for a unique extracellular alcohol/imidazobenzodiazepine Ro15-4513 binding site at the α+β- subunit interface in αβ3δ GABAA receptors.
Wallner M; Hanchar HJ; Olsen RW
Neurochem Res; 2014 Jun; 39(6):1118-26. PubMed ID: 24500446
[TBL] [Abstract][Full Text] [Related]
31. Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse.
Hondebrink L; Meulenbelt J; van Kleef RG; van den Berg M; Westerink RH
Neurotoxicology; 2011 Dec; 32(6):823-7. PubMed ID: 21729720
[TBL] [Abstract][Full Text] [Related]
32. Allosteric modulation of GABAA receptors via multiple drug-binding sites.
Sieghart W
Adv Pharmacol; 2015; 72():53-96. PubMed ID: 25600367
[TBL] [Abstract][Full Text] [Related]
33. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E
J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789
[TBL] [Abstract][Full Text] [Related]
34. The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors.
Weir CJ; Ling AT; Belelli D; Wildsmith JA; Peters JA; Lambert JJ
Br J Anaesth; 2004 May; 92(5):704-11. PubMed ID: 15033889
[TBL] [Abstract][Full Text] [Related]
35. Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?
Savić MM; Majumder S; Huang S; Edwankar RV; Furtmüller R; Joksimović S; Clayton T; Ramerstorfer J; Milinković MM; Roth BL; Sieghart W; Cook JM
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):376-86. PubMed ID: 20074611
[TBL] [Abstract][Full Text] [Related]
36. Novel Molecule Exhibiting Selective Affinity for GABA
Borghese CM; Herman M; Snell LD; Lawrence KJ; Lee HY; Backos DS; Vanderlinden LA; Harris RA; Roberto M; Hoffman PL; Tabakoff B
Sci Rep; 2017 Jul; 7(1):6230. PubMed ID: 28740086
[TBL] [Abstract][Full Text] [Related]
37. The dual modulatory effects of efavirenz on GABA
Huang R; Chen Z; Dolan S; Schetz JA; Dillon GH
Neuropharmacology; 2017 Jul; 121():167-178. PubMed ID: 28456686
[TBL] [Abstract][Full Text] [Related]
38. The effect of a transmembrane amino acid on etomidate sensitivity of an invertebrate GABA receptor.
McGurk KA; Pistis M; Belelli D; Hope AG; Lambert JJ
Br J Pharmacol; 1998 May; 124(1):13-20. PubMed ID: 9630337
[TBL] [Abstract][Full Text] [Related]
39. An intersubunit electrostatic interaction in the GABA
Pflanz NC; Daszkowski AW; Cornelison GL; Trudell JR; Mihic SJ
J Biol Chem; 2018 May; 293(21):8264-8274. PubMed ID: 29622679
[TBL] [Abstract][Full Text] [Related]
40. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
Fernandez SP; Mewett KN; Hanrahan JR; Chebib M; Johnston GA
Neuropharmacology; 2008 Oct; 55(5):900-7. PubMed ID: 18657554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
